Dose Banded and Patient Specific Doses of Systemic Anti-Cancer Treatments (SACT)
Estimated value
£6.0m
Awarded value
£6.0m
Suppliers
1
Lots
1
Published
11 Jun 2019
Description
The Trust is the cancer centre for North East London and provides a medical and haematological oncology service including bone marrow transplantation. The chemotherapy pharmacy department has a licensed chemotherapy production unit, providing over 45,000 doses of systemic anti-cancer treatments (SACT) per year. Demand for the provision of SACT has been rising consistently year on year. As such the department has developed a strategy to meet this demand and ensure that patient treatment requirements can be met. This strategy includes maximising efficiency of our existing production capacity by outsourcing doses that can be manufactured externally, to quality standards and that will be safe for the patient. The outsourced doses will be purchased in the form of both readymade dose banded products and patient specific doses.
Scope
- Reference
- LPPBARTS001-DN406495-99105398
- Total value
- £6,000,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Aug 2019 to 30 Aug 2024
- CPV classifications
- 85149000
Submission & procedure
- Submission deadline
- 09 Jun 2019, 11:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£6.0m
Award date
10 Jun 2019
Contract start
31 Aug 2019
Contract end
30 Aug 2024